Physician profile
Marshall D Shaw
NPI 1225442841
$6,697.64
in general payments reported to CMS, 2019-2025
51 companies · $919 in 2025
The $919 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,338 · 2020: $263 · 2021: $512 · 2022: $771 · 2023: $700 · 2024: $1,195 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,594 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,593.67 |
| Education | $220.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,321.90 | 2019-2025 | Spaceoar System, Axonics, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $579.86 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $308.83 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $302.01 | 2021-2025 | Urolift, Barrigel |
| Myriad Genetic Laboratories, INC. | $247.02 | 2020-2025 | Prolaris, Myrisk |
| Procept Biorobotics Corporation | $235.73 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $204.77 | 2020-2025 | Lupron Depot |
| Coloplast Corp | $172.25 | 2019-2025 | |
| Medtronic, INC. | $139.17 | 2021-2025 | Interstim |
| Endo Pharmaceuticals INC. | $135.71 | 2019-2022 | |
| Healthtronics Stone Solutions, LLC | $125.44 | 2019 | |
| Pfizer INC. | $120.71 | 2019-2025 | |
| Accord Healthcare, INC. | $114.61 | 2023-2025 | |
| Urogen Pharma, INC. | $113.35 | 2021-2025 | Jelmyto |
| Axonics, INC. | $112.85 | 2020-2024 | Axonics, Bulkamid |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $96.59 | 2021-2025 | Resonance, Cook, Litho 150 |
| Endo USA, INC. | $86.94 | 2024-2025 | Xiaflex |
| Calyxo, INC. | $84.10 | 2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $82.09 | 2024-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $80.67 | 2022-2023 | |
| Myovant Sciences INC. | $79.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $67.95 | 2022-2025 | Imfinzi |
| Janssen Biotech, INC. | $67.91 | 2019-2023 | Erleada |
| Neotract INC. | $60.25 | 2019-2020 | |
| Ambu INC. | $59.03 | 2020-2025 | |
| Sobi, INC | $55.25 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $48.24 | 2023-2024 | |
| Allergan, INC. | $45.22 | 2020-2021 | |
| Olympus America INC. | $40.49 | 2025 | Itind System |
| Blue Earth Diagnostics | $40.37 | 2022 | |
| Civco Medical Instruments | $39.46 | 2025 | |
| Travere Therapeutics, INC. | $37.03 | 2021-2022 | |
| Urovant Sciences INC | $35.62 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $35.39 | 2020-2021 | |
| Tolmar, INC. | $31.99 | 2024-2025 | Eligard, Jatenzo |
| Rigel Pharmaceuticals, INC. | $31.61 | 2023 | Tavalisse, Rezlidhia |
| Genzyme Corporation | $30.48 | 2022 | |
| Tersera Therapeutics LLC | $25.40 | 2022 | |
| Ethicon US, LLC | $20.34 | 2025 | Stratafix |
| Karl Storz Endoscopy-America | $18.70 | 2023 | |
| Amgen INC. | $18.21 | 2023 | Vectibix, Xgeva, Nplate |
| Siemens Medical Solutions USA, INC. | $17.68 | 2022 | |
| Merck Sharp & Dohme LLC | $16.85 | 2021 | |
| Emd Serono, INC. | $16.69 | 2022 | |
| Medtronic USA, INC. | $14.83 | 2020 | |
| Laborie Medical Technologies Corp. | $13.87 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Hollister Incorporated | $13.81 | 2023 | Onli, Infyna Chic, Vapro Pocket |
| Antares Pharma, INC. | $13.38 | 2021 | |
| Dendreon Pharmaceuticals LLC | $13.27 | 2019 | |
| Bard Access Systems, INC. | $12.58 | 2019 | |
| Seagen INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.